Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/79251
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRusso, Paul A. J.en
dc.contributor.authorWiese, Michaelen
dc.contributor.authorSmith, Malcolm D.en
dc.contributor.authorAhern, Michael J.en
dc.contributor.authorBarbara, Jeffrey Allan J.en
dc.contributor.authorShanahan, Michael E.en
dc.date.issued2013en
dc.identifier.citationAnnals of Pharmacotherapy, 2013; 47(3):e15en
dc.identifier.issn1060-0280en
dc.identifier.urihttp://hdl.handle.net/2440/79251-
dc.description.statementofresponsibilityPaul AJ Russo, Michael D Wiese, Malcolm D Smith, Michael J Ahern, Jeffrey A Barbara, E Michael Shanahanen
dc.language.isoenen
dc.publisherHarvey Whitney Booksen
dc.rights© 1967-2013 Harvey Whitney Books Co. All rights reserved.en
dc.titleLeflunomide for inflammatory arthritis in end-stage renal disease on peritoneal dialysis: A pharmacokinetic and pharmacogenetic studyen
dc.typeJournal articleen
dc.contributor.schoolSchool of Molecular and Biomedical Scienceen
dc.identifier.doi10.1345/aph.1R542en
Appears in Collections:Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.